Humasis has ranked among the top searched stocks for 6 days in the past month.

As of 12:33 PM on the 22nd, Humasis is trading at 11,850 KRW, up 29.93% from the previous day. This represents a 272.06% increase compared to June 9. Humasis is known as an in vitro diagnostic device company.

Today, foreigners have sold a net 57,000 shares of Humasis, and institutions have sold a net 1,000 shares, according to preliminary data. Over the past 5 days, individual investors have bought a net 438,586 shares, while foreigners and institutions have sold a net 89,000 shares and 463,810 shares, respectively.

On June 19, Humasis became a market topic with the headline "Four consecutive trading days of sharp rise on 'Celltrion collaboration good news'."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing